NCR-101

N/A

Report date: 2025/02/20 16:31:40

Base Information

Drug NameNCR-101
Drug Alias NameNCR101NCR-101
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Source of cells > iPSC-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsLung Diseases, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAnhui Nuwacell Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhongsheng Traceability (Guangzhou) Biotechnology Co LtdAnhui Nuwacell Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsLung Diseases, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A